|Ms. Janelle D' Alvise||Pres, CEO, Corp. Sec. & Director||N/A||N/A||N/A|
|Dr. Pierre Lemieux||Co-Founder and COO & Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Jean-François Boily||VP of Fin.||N/A||N/A||N/A|
|Mr. Brian James Groch||Chief Commercial Officer||N/A||N/A||1967|
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acasti Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.